curium

Curium Announces First Commercial Doses of PYLCLARI for Patients with Prostate Cancer in Poland

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec.…

3 weeks ago

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of64Cu-PSMA-I&T for Prostate Cancer in Japan

PARIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Curium Group announced today that together with PeptiDream Inc. and PDRadiopharma Inc., a…

3 months ago